| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |